Protagonist Therapeutics

Filed a patent for "peptide inhibitors of interleukin-23 receptor" on Mon, January 16, 2023

Filed a patent for "peptide inhibitors of interleukin-23 receptor" on Mon, January 16, 2023

Filed a patent for "conjugated hepcidin mimetics" on Thu, June 27, 2024

Filed a patent for "a4b7 thioether peptide dimer antagonists" on Thu, June 27, 2024

Filed a patent for "combination therapy for treatment of iron overload diseases" on Thu, July 7, 2022

Filed a patent for "conjugated hepcidin mimetics" on Thu, September 21, 2023

Filed a patent for "conjugated hepcidin mimetics" on Thu, January 18, 2024

Filed a patent for "conjugated hepcidin mimetics" on Thu, February 29, 2024

Filed a patent for "methods for treating inflammatory bowel diseases with a4b7 integrin antagonists" on Thu, November 30, 2023

Filed a patent for "hepcidin mimetics for treatment of sickle cell disease" on Thu, January 18, 2024

Filed a patent for "hepcidin analogues and uses thereof" on Thu, May 30, 2024

Filed a patent for "conjugated hepcidin mimetics" on Fri, September 29, 2023

Filed a patent for "conjugated hepcidin mimetics" on Fri, September 29, 2023

Filed a patent for "hepcidin mimetics for treatment of hereditary hemochromatosis" on Wed, December 13, 2023

Filed a patent for "conjugated hepcidin mimetics" on Wed, March 30, 2022

Filed a patent for "conjugated hepcidin mimetics" on Wed, March 30, 2022

Filed a patent for "methods for treating inflammatory bowel diseases with alpha-4-beta-7 integrin antagonists" on Mon, April 25, 2022

Filed a patent for "hepcidin mimetics for treatment of sickle cell disease" on Tue, June 7, 2022

Filed a patent for "hepcidin mimetics for treatment of hereditary hemochromatosis" on Tue, June 7, 2022

Filed a patent for "methods for treating inflammatory bowel diseases with alpha4beta7 integrin antagonists" on Thu, March 2, 2023

Filed a patent for "peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases" on Thu, April 27, 2023